David H. Trotter, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1585 Barrington Rd, Suite 101, Hoffman Estates, IL 60169 Phone: 847-884-7771 Fax: 847-884-0666 |
Sanjay Kirit Patari, MD Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 1585 N. Barrington Rd, Suite 101, Hoffman Estates, IL 60169 Phone: 847-884-7771 Fax: 847-884-0666 |
Bruce J Goldberg, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1555 Barrington Rd, Ste 205, Hoffman Estates, IL 60169 Phone: 630-480-0490 Fax: 630-580-9641 |
Theodore J. Suchy, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1585 N. Barrington Rd, Suite 101, Hoffman Estates, IL 60169 Phone: 847-884-7771 Fax: 847-884-0666 |
Dr. Sheryl Lynn Lipnick, D.O. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1585 N. Barrington Rd Ste 101, Drs. Bldg. 2, Hoffman Estates, IL 60169 Phone: 847-884-7771 |
News Archive
In neonates with probable sepsis or meningitis, a realtime polymerase chain reaction assay specific for a virulence gene in Streptococcus agalactiae is superior to standard bacterial culture identification, results of a pathology study show.
The FDA is warning consumers not to eat alfalfa sprouts or spicy sprouts from plastic bags labeled "Evergreen Produce" or "Evergreen Produce Inc."
Researchers at the California Teratogen Information Service (CTIS) Pregnancy Health Information Line, a statewide non-profit organization based at the University of California, San Diego School of Medicine, have found women exposed to certain antidepressants during pregnancy were significantly less likely to breastfeed their babies compared to unexposed women.
Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.
› Verified 3 days ago